Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement
1 other identifier
observational
32
1 country
1
Brief Summary
The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of CEA levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 2, 2011
CompletedFirst Posted
Study publicly available on registry
December 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedDecember 12, 2014
December 1, 2014
1.3 years
December 2, 2011
December 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of diluted CEA level
The primary aim of this study is to determine if pancreatic cyst fluid can be diluted and provide an accurate CEA level.
Pancreatic fluid is aspirated once during the procedure.
Study Arms (1)
EUS-FNA of Pancreatic Cyst
Patients who have a pancreatic cyst requiring standard of care EUS-FNA that yields 2.25 ML (or greater) of fluid will be included in the study.
Interventions
There is no intervention. Extra fluid that is normally discarded will be processed.
Eligibility Criteria
Patients who are already scheduled for EUS-FNA of a pancreatic cyst at the H.H. Chao Comprehensive Digestive Disease Center at UC Irvine Medical Center. The procedure will be performed as usual per standard of care protocol with EUS-FNA of the cyst. Once the fluid is aspirated, it will be measured and if the fluid volume is 2.25 mL or greater than the patient will be included in the study.
You may qualify if:
- Patients scheduled for EUS-FNA of a pancreatic cyst
- Cyst must yield 2.25ml (or greater) of fluid
You may not qualify if:
- Cysts yielding less than 2.25ml of fluid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
H. H. Chao Comprehensive Digestive Disease Center
Orange, California, 92868, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth J. Chang, MD
University of California, Irvine
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical Medicine
Study Record Dates
First Submitted
December 2, 2011
First Posted
December 16, 2011
Study Start
April 1, 2011
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
December 12, 2014
Record last verified: 2014-12